factually
Index/Topics/503A vs 503B Compounding Pharmacies

503A vs 503B Compounding Pharmacies

Comparison of 503A and 503B compounding pharmacies in terms of oversight, standards, and production of compounded medications, specifically GLP-1 peptides.

Fact-Checks

2 results
Jan 25, 2026
Most Viewed

How do 503A and 503B compounding pharmacies differ in regulation and patient risk?

compounding pharmacies are two legally distinct pathways to balance individualized patient needs against public-health scale manufacturing: 503A are , patient‑specific compounders largely overseen by ...

Jan 26, 2026

What differences in safety oversight exist between 503A and 503B compounding pharmacies for GLP‑1 products?

produce patient‑specific compounds under state board oversight and standards, while 503B “outsourcing facilities” are federally registered, can make bulk sterile products and face stricter controls su...